Patent Assignment
Reel/Frame 069806/0458
Assignment of Assignor's Interest
Recorded: 2025-01-09
Pages: 20
Assignor
NABRIVA THERAPEUTICS GMBH
Executed: 2024-12-06
Assignee
HONG KONG KING-FRIEND INDUSTRIAL COMPANY LTD.
16 XUEFU ROAD, HIGH & NEW TECH DEVELOPMENT ZONE, NANJING, 210061, CHINA
Covered Properties
(22)
Organic Compounds
Application:
11/828,224 →
Publication:
US 2009/0118366
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
13/438,160 →
Publication:
US 2013/0040954
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
14/283,734 →
Publication:
US 2014/0256731
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
15/480,756 →
Publication:
US 2017/0266194
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
16/023,880 →
Publication:
US 2018/0303842
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
16/277,143 →
Publication:
US 2019/0175603
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
16/593,449 →
Publication:
US 2020/0030335
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
16/881,117 →
Publication:
US 2020/0281933
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
17/138,097 →
Publication:
US 2021/0113571
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
17/401,418 →
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Application:
17/702,304 →
Publication:
US 2022/0218713
Enantiomerically Pure Amines
Process for the Preparation of Pleuromutilins
Injectable Pharmaceutical Formulations of Lefamulin
Injectable Pharmaceutical Formulations of Lefamulin
Application:
18/891,571 →
Publication:
US 2025/0009885
Purification of Pleuromutilin
Novel Therapeutic Use of Pleuromutilins
Application:
17/919,202 →
Publication:
US 2023/0218558
Therapeutic Use of Pleuromutilins
Application:
17/919,200 →
Publication:
US 2023/0174472
Therapeutic Use of Pleuromutilins
Application:
18/837,088 →
Publication:
US 2025/0134844
Pleuromutilin Derivatives for the Treatment of Diseases Mediated by Microbes
Related Assignments
(25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Dec 18, 2007
From: MANG, ROSEMARIE; HEILMAYER, WERNER; BADEGRUBER, RUDOLF; STRICKMANN, DIRK
To: NABRIVA THERAPEUTICS FORSCHUNGS GMBH
Reel/Frame 020268/0923 →
Assignment of Assignor's Interest
Sep 17, 2009
From: MANG, ROSEMARIE; HEILMAYER, WERNER; BADEGRUBER, RUDOLF; STRICKMANN, DIRK B.
To: NABRIVA THERAPEUTICS AG
Reel/Frame 023249/0229 →
Assignment of Assignor's Interest
Feb 22, 2012
From: MANG, ROSEMARIE; HEILMAYER, WERNER; BADEGRUBER, RUDOLF; STRICKMANN, DIRK B.
To: NABRIVA THERAPEUTICS AG
Reel/Frame 027745/0615 →
Assignment of Assignor's Interest
Nov 27, 2012
From: RIEDL, ROSEMARIE; HEILMAYER, WERNER; SPENCE, LEE; BULUSU, ATCHYUTA RAMA CHANDRA MURTY
To: NABRIVA THERAPEUTICS AG
Reel/Frame 029355/0554 →
Assignment of Assignor's Interest
Dec 10, 2012
From: RIEDL, ROSEMARIE; HEILMAYER, WERNER; SPENCE, LEE
To: NABRIVA THERAPEUTICS AG
Reel/Frame 029439/0875 →
Assignment of Assignor's Interest
Apr 9, 2013
From: MANG, ROSEMARIE; HEILMAYER, WERNER; BADEGRUBER, RUDOLF; STRICKMANN, DIRK B.
To: NABRIVA THERAPEUTICS AG
Reel/Frame 030177/0294 →
Lien
Sep 3, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033659/0216 →
Assignment of Assignor's Interest
Oct 13, 2014
From: NABRIVA THERAPEUTICS AG
To: KREOS CAPITAL IV (UK) LIMITED
Reel/Frame 033935/0048 →
Assignment of Assignor's Interest
Oct 13, 2014
From: MANG, ROSEMARIE; HEILMAYER, WERNER; BADEGRUBER, RUDOLF; STRICKMANN, DIRK B.
To: NABRIVA THERAPEUTICS AG
Reel/Frame 033934/0969 →
Release of Security Interest
Nov 19, 2015
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 037093/0308 →
Corrective Assignment to Correct the Application No. in the Release by Secured Party from 12/699585 to 13/699585 Previously Recorded on Reel 037093 Frame 0308. Assignor(S) Hereby Confirms the Release Agreement.
Dec 2, 2015
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 037190/0424 →
Release of Security Interest
Sep 29, 2016
From: KREOS CAPITAL IV (UK) LIMITED
To: NABRIVA THERAPEUTICS AG
Reel/Frame 039894/0473 →
Assignment of Assignor's Interest
Apr 24, 2017
From: MANG, ROSEMARIE; HEILMAYER, WERNER; BADEGRUBER, RUDOLF; STRICKMANN, DIRK B.
To: NABRIVA THERAPEUTICS AG
Reel/Frame 042126/0873 →
Assignment of Assignor's Interest
Mar 7, 2018
From: FERENCIC, MATHIAS; HEILMAYER, WERNER; HINSMANN, PETER; WICHA, WOLFGANG
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 045131/0353 →
Change of Name
May 17, 2018
From: NABRIVA THERAPEUTICS AG
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 047658/0862 →
Change of Name
Jul 18, 2018
From: NABRIVA THERAPEUTICS AG
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 047958/0106 →
Intellectual Property Security Agreement
Dec 20, 2018
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 047973/0110 →
Security Interest
Jan 18, 2019
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 048062/0807 →
Assignment of Assignor's Interest
Aug 1, 2019
From: HEILMAYER, WERNER; SPENCE, LEE; HINSMANN, PETER
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 049930/0721 →
First Supplement to Intellectual Property Security Agreement
Mar 20, 2020
From: NABRIVA THERAPEUTICS GMBH
To: HERCULES CAPITAL, INC.
Reel/Frame 052201/0503 →
Release of Security Interest
Mar 3, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH; ZAVANTE THERAPEUTICS, INC.
Reel/Frame 062881/0090 →
Assignment of Assignor's Interest
Apr 28, 2023
From: HAFNER, MICHAEL; PAUKNER, SUSANNE; WICHA, WOLFGANG; RIEDL, ROSEMARIE
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 063480/0198 →
Assignment of Assignor's Interest
Jun 5, 2023
From: PAUKNER, SUSANNE; WICHA, WOLFGANG; GELONE, STEVEN PETER; ASCHER, GERD
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 063854/0225 →
Corrective Assignment to Correct the Receiving Party Data and the Assignment Document Previously Recorded at Reel: 062881 Frame: 0090. Assignor(S) Hereby Confirms the Release of Security Interest.
Jun 20, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 064312/0350 →
Release of Security Interest
Jul 20, 2023
From: HERCULES CAPITAL, INC.
To: NABRIVA THERAPEUTICS GMBH
Reel/Frame 064326/0977 →